The Relationship Between Anti-Tuberculosis Drug Therapy and Uric Acid and Creatinine Levels in Tuberculosis Patients in Kayong Utara District
DOI:
https://doi.org/10.53770/medica.v7i2.513Keywords:
Tuberculosis, Anti-Tuberculosis Drugs, Uric Acid, CreatinineAbstract
Pulmonary tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis. TB treatment involves five essential drugs: isoniazid, streptomycin, ethambutol, rifampicin, and pyrazinamide. Among these, pyrazinamide and ethambutol are known to potentially increase uric acid and creatinine levels as side effects. This study aimed to examine the relationship between anti-TB drug (OAT) therapy and levels of uric acid and creatinine in TB patients in Kayong Utara District. Using a cross-sectional design and purposive sampling, data were collected from 31 TB patients across three community health centers with the highest TB incidence. Results showed that 54.8% of patients had elevated uric acid levels, while 45.2% had normal levels. For creatinine, 93.5% had normal levels, and 6.5% had elevated levels. Chi-square analysis indicated a significant association between OAT therapy and uric acid levels (p = 0.045), but no significant relationship was found with creatinine levels (p = 1.000). These findings suggest that OAT therapy may affect uric acid levels in TB patients, highlighting the need for monitoring during treatment.
References
Dinas Kesehatan Provinsi Kalimantan Barat. (2022). LAKIP Final 2022. Pontianak: Dinas Kesehatan Provinsi Kalimantan Barat. Retrieved from: https://datacloud.kalbarprov.go.id/index.php/s/MJDRt6g3PeE3SGF#pdfviewer
Direktoral Jenderal Pelayanan Kesehatan. (2022). Pengaruh Makanan Mengandung Purin Dengan Asam Urat. Jakarta: Kementerian Kesehatan Republik Indonesia.
Harison, M. F. (2019). Gambaran Kadar Ureum dan Kreatinin pada Penderita Tuberkulosis Paru yang Mendapat Terapi Obat Anti Tuberkolosis (OAT) di RS. Khusus Paru di RS. Khusus Paru Provinsi Sumatera Selatan Tahun 2019. Diploma Thesis. Politeknik Kesehatan Palembang.
Handayani, T. L. (2017). Faktor Dominan Peningkatan Kadar Asam Urat Pada Arthritis di Wilayah Kerja Puskesmas di Kabupaten Jember. Jurnal Riset Kesehatan Nasional, 1(2), 95-101.
Jumria, J. (2023). Gambaran Kadar Kreatinin Pada Pasien Tuberkulosis Paru Dengan Pengobatan OAT Kategori 1 Di Puskesmas Temindung Dan Puskesmas Remaja Tahun 2022. Diploma Thesis. Jurusan Teknologi Laboratorium Medik, Politeknik Kesehatan Kementerian Kesehatan Kalimantan Timur.
Kementerian Kesehatan Republik Indonesia. (2019). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Jakarta: Kementerian Kesehatan Republik Indonesia
Kementerian Kesehatan Republik Indonesia. (2020). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Jakarta: Kementerian Kesehatan Republik Indonesia
Kementerian Kesehatan Republik Indonesia. (2023). Laporan Program Penanggulangan Tuberkulosis Tahun 2022. Jakarta: Kementerian Kesehatan Republik Indonesia
Madyaningrum, E., Kusumaningrum, F., Wardani, R. K., Susilaningrum, A. R., & Ramdhani, A. (2020). Buku Saku Kader: Pengontrolan Asam Urat di Masyarakat. Yogyakarta: Fakultas Kedokteran, Kesehatan Masyarakat dan Keperawatan (FK-KMK) UGM.
Natania, N., & Malinti, E. (2020). Hubungan Aktivitas Fisik Dengan Kadar Asam Urat Di RW 13 Kampung Mokla, Kecamatan Parongpong. Klabat Journal of Nursing, 2(2), 17-24. https://doi.org/10.37771/kjn.v2i2.488
Mihardjal, L., Lolong, D. B., & Ghani, L. (2015). Prevalensi Diabetes Melitus Pada Tuberkulosis. Indonesian Journal of Health Ecology, 14(4), 350-358.
Muhammad, E. Y. (2019). Hubungan tingkat pendidikan terhadap kejadian tuberkulosis paru. Jurnal Ilmiah Kesehatan Sandi Husada, 8(2), 288-291. Retrieved from: https://jurnalsandihusada.polsaka.ac.id/JIKSH/article/view/173
Nafila, N., Haqiqi, R. N., & Wahyunita, S. (2017). Kadar asam urat pada pasien tuberkulosis dengan terapi obat anti tuberkulosis (OAT) di Puskesmas Cempaka Maret 2017. Jurnal Ilmiah Manuntung: Sains Farmasi Dan Kesehatan, 3(2), 173-177. Retrieved from: https://jurnal.stiksam.ac.id/index.php/jim/article/view/124
Ningsih, A. S. W., Ramadhan, A. M., & Rahmawati, D. Proceeding of Mulawarman Pharmaceuticals Conferences, 15, 231–241. https://doi.org/10.25026/mpc.v15i1.647
Nuraeni, V., Kurniawan, E., & Atfal, B. (2018). Profil Kadar Asam Urat Terhadap Penderita Tuberkulosis Yang Sudah Mengkonsumsi Obat Anti Tuberkulosis (OAT) Pirazinamid dan Etambuthol Tahun 2018. Media of Medical Laboratory Science, 2(2), 58-63.
Pham, A. Q., Doan, A., & Andersen, M. (2014). Pyrazinamide-induced hyperuricemia. Pharmacovigilance Forum, 39(10), 695–715. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/25336865/
Purnasari, C., Manggau, M. A., & Kasim, H. (2018). Studi Pengaruh Dosis Dan Lama Penggunaan Terapi Aminoglikosida Terhadap Fungsi Ginjal. Majalah Farmasi Dan Farmakologi, 22(3), 76–80. https://doi.org/10.20956/mff.v22i3.5807
Singh, N. P., Ganguli, A., & Prakash, A. (2003). Drug-induced kidney diseases. The Journal of the Association of Physicians of India, 51, 970–979. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/14719587/
Ulfah, U. (2021). Tuberkulosis Gambaran Kadar Asam Urat Pada Penderita Tuberkulosis Paru Yang Mengkonsumsi Obat Anti Tuberkulosis (OAT). Jurnal Kesehatan Rajawali, 11(2), 40-45. https://doi.org/10.54350/jkr.v11i2.108
Wibowo, W., Mulia, Y. S., Sunarno, S., Su’udi, A., Putranto, R. H., Kusumawati, K., & Renitia, G. I. (2023). Analisis Kadar Ureum, Creatinin, Dan Asam Urat Pada Oat Tb-Paru. Jurnal Riset Kesehatan Poltekkes Depkes Bandung, 15(2), 442-449. https://doi.org/10.34011/juriskesbdg.v15i2.2222
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 MEDICA (International Medical Scientific Journal)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
